HEALTHEQUITY, INC. HQY Cash Flow

Healthequity, inc. (HQY)

CashFlow / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14
Cash flows from operating activities:
Net income
39,664	52,973	89,993	93,144	73,899	66,685	61,481	55,910	47,362	45,519	41,045	32,332	26,376	25,442	23,521	19,709	16,613	14,856	13,818	12,425	10,166	0	0	0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
55,352	33,478	18,991	18,438	18,185	18,308	17,732	16,990	15,952	14,785	14,197	13,721	13,186	12,414	11,061	9,798	8,601	7,433	6,912	6,389	5,890	0	0	0
Deferred taxes
3,665	704	5,925	5,961	408	-393	1,958	3,077	4,306	4,082	2,546	293	-2,891	-2,553	-1,783	-2,142	-2,178	-1,938	-1,387	639	1,593	0	0	0
Stock-based compensation
39,844	36,790	24,948	22,846	21,057	19,303	17,234	15,539	14,310	12,467	10,870	9,586	8,398	8,028	7,443	6,611	5,883	5,986	4,828	3,554	2,525	0	0	0
(Gains) losses on marketable equity securities and other
23,151	25,025	26,093	22,451	-1,173	-1,395	-656	-696	-597	-54	33	37	96	76	59	41	23	0	0	0	-	-	-	-
Loss on revaluation of redeemable convertible preferred stock derivative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	735	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
5,009	4,260	2,691	4,240	4,306	3,115	4,165	4,167	4,734	7,454	4,228	3,317	2,728	4,062	5,746	5,147	5,174	3,899	4,599	4,460	3,380	0	0	0
Inventories
-	-	-	-	-	-	-	-	-	0	0	-69	-	129	109	-69	-5	59	221	271	234	0	0	0
Other assets
12,577	6,262	4,008	2,116	5,893	2,301	3,608	5,024	760	415	171	-2,189	1,343	2,641	1,741	3,975	107	905	2,823	2,299	1,608	0	0	0
Operating lease right-of-use assets
-6,218	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
-3,839	2,474	617	-801	863	-1,243	77	1,051	-581	1,115	141	263	567	-377	219	110	1,011	801	472	124	-1,156	0	0	0
Accrued compensation
4,550	-963	1,332	861	4,432	3,429	3,203	3,315	3,827	1,844	2,167	1,722	946	761	1,041	562	2,475	889	306	275	1,167	0	0	0
Accrued liabilities and other current liabilities
5,759	16,235	7,917	3,919	3,031	-1,651	-360	740	484	2,649	1,802	1,190	1,729	715	-133	880	-383	306	-53	-329	-802	0	0	0
Operating lease liabilities, non-current
-5,383	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Other long-term liabilities
-83	82	606	485	573	610	626	766	939	931	991	881	1,220	1,100	931	342	-252	-286	-290	55	95	0	0	0
Net cash provided by operating activities
105,010	106,707	117,613	116,054	113,422	100,604	94,581	88,830	81,702	76,445	69,814	59,055	45,591	38,798	34,787	26,882	26,541	23,239	17,018	15,354	15,046	0	0	0
Cash flows from investing activities:
Purchases of marketable securities
53,845	53,999	54,205	54,393	728	714	627	554	483	447	426	402	379	353	331	315	40,291	40,213	40,137	40,062	0	0	0	0
Purchases of property and equipment
7,286	5,582	4,671	3,874	3,869	5,543	5,987	5,142	5,458	4,322	4,556	4,761	3,645	3,199	2,369	1,871	2,376	2,117	1,922	2,058	1,712	0	0	0
Purchases of software and capitalized software development costs
25,654	19,858	14,795	13,378	9,978	10,078	9,915	9,749	10,380	9,885	10,236	9,755	9,030	8,938	7,874	7,448	6,896	6,326	5,886	6,159	6,420	0	0	0
Acquisition of intangible member assets
9,134	9,070	1,917	2,457	1,195	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
-1,740,494	-1,677,153	-34,166	-32,680	25,652	-19,546	-28,455	-35,872	-36,748	-33,065	-24,733	-14,918	-13,054	-19,158	-51,563	-50,623	-90,552	-82,977	-48,250	-48,584	-8,437	0	0	0
Cash flows from financing activities:
Proceeds from exercise of common stock options
11,347	8,933	11,024	16,991	22,929	23,582	25,961	20,902	14,564	14,916	13,086	10,826	7,142	4,710	1,890	1,567	1,915	1,784	1,200	2,672	2,430	0	0	0
Proceeds from exercise of common stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,380	0	0	0
Tax benefit from exercise of common stock options
-	-	-	-	-	-	-	-	-	-	-	-	16,634	16,151	15,521	16,904	11,557	17,718	16,600	7,514	3,429	0	0	0
Net cash provided by financing activities
1,465,735	1,455,996	469,905	16,991	22,929	23,582	25,961	20,902	14,564	15,641	15,471	18,182	23,776	20,697	17,094	41,646	36,647	36,893	119,197	94,101	90,479	0	0	0
Increase (decrease) in cash and cash equivalents
-169,749	-114,450	553,352	100,365	162,003	104,640	92,087	73,860	59,518	59,021	60,552	62,319	56,313	40,337	318	17,905	-27,364	-22,845	87,965	60,871	97,088	0	0	0
Supplemental cash flow data:
Interest expense paid in cash
21,806	290	203	203	203	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes paid in cash, net of refunds received
9,277	9,086	9,152	497	587	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable or accrued liabilities at period end
487	199	26	-433	37	-232	-39	358	0	-306	-301	150	25	393	424	53	45	0	0	0	-	-	-	-
Exercise of common stock options receivable
-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of common stock warrants to common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,334	0	0	0
Series D-3 redeemable convertible preferred stock dividend
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Software
Purchases of intangible assets
1,742	360	512	241	200	0	0	0	-	-	-	0	-	-	-	238	-	0	0	0	-	-	-	-